You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-5 part (iii). Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Demographics and injecting status of all men entering treatment

Country

 

Year

Mean age


Age <25 (%)


Age 35+ (%)

% currently injecting any drug

Belgium

(1)

1999

25.5

54.0

13.0

7.8

Czech Republic

 

2003

24.3

60.0

8.0

49.0

Denmark

 

2003

31.5

25.2

34.4

15.6

Germany

 

2003

28.0

43.0

22.0

3.1

Greece

 

2003

28.6

39.1

22.1

51.1

Spain

(2)

2002

 

 

 

 

France

(3)

2003

33.9

20.4

35.5

13.9

Ireland

(4)

2002

25.9

50.0

12.9

24.9

Italy

 

2003

32.8

15.7

40.1

 

Cyprus

 

2003

27.5

43.7

17.8

51.1

Latvia

 

2003

23.3

69.0

6.0

59.4

Lithuania

 

2003

 

 

 

 

Luxembourg

 

2003

31.5

18.2

38.4

76.0

Hungary

 

2003

27.5

45.0

16.0

 

Malta

 

2003

25.0

50.7

9.1

28.7

Netherlands

 

2003

33.1

22.0

39.0

2.5

Austria

(5)

2003

33.7

17.5

46.7

 

Poland

(6)

2002

 

 

 

 

Portugal

(7)

2003

31.4

18.6

32.0

30.2

Slovenia

(8)

2003

25.9

49.6

10.2

42.0

Slovakia

 

2003

24.8

55.7

7.2

53.8

Finland

 

2003

26.6

48.3

15.1

52.1

Sweden

 

2003

32.0

30.8

37.2

36.0

United Kingdom

(9)

2003

30.4

27.9

26.5

21.0

Bulgaria

 

2003

23.4

69.9

3.2

80.0

Romania

 

2003

26.6

60.0

12.0

 

Notes:  

Data were not available for: Estonia, Norway, Turkey

(1) Last data available refer to 1999.

(2) Last data available refer to 2002.

(3) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003.

(4) Last data available refer to 2002.

(5) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%.

(6) Last data available refer to 2002. Only data available on first treatment is the total number of cases.

(7) Data by gender refer to first treatments.

(8) Data refer only to outpatient treatment centres.

(9) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2000 and 31 March 2001 combined.

(11) Data refer only to outpatient treatment centres.

(12) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2000 and 31 March 2001 combined.

Sources:

2004 Reitox national reports - standard table 3

See [Table TDI-1] for details on sources.

Data filter | tditab05c-en.xml